Drug – bio-affecting and body treating compositions – Inorganic active ingredient containing – Phosphorus or phosphorus compound
Reexamination Certificate
2005-09-27
2005-09-27
Lilling, Herbert J. (Department: 1651)
Drug, bio-affecting and body treating compositions
Inorganic active ingredient containing
Phosphorus or phosphorus compound
C424S602000, C424S725000, C424S734000, C424S757000
Reexamination Certificate
active
06949260
ABSTRACT:
A composition for treating inflammation and pain in mammals, particularly humans. Effective amounts of a boswellic acid, a curcuminoid, a gingerol, a capsaicinoid, a bioflavonoid, and a vitamin C source, in various combinations, all preferably from a botanical source, are blended to form a dose for oral administration. Administration of the dose provides relief from pain and inflammation of connective tissue. The dose may be administered as a tablet, a liquid, or a powder.
REFERENCES:
patent: 5804594 (1998-09-01), Murad
patent: 5885597 (1999-03-01), Botknecht et al.
patent: 5972382 (1999-10-01), Majeed et al.
patent: 6210701 (2001-04-01), Darland et al.
patent: 6344220 (2002-02-01), Rose et al.
patent: 6352712 (2002-03-01), Lukaczer et al.
patent: 6358539 (2002-03-01), Murad
patent: 6492429 (2002-12-01), Graus et al.
patent: WO 00/12085 (2000-03-01), None
patent: WO 02/07768 (2002-01-01), None
Datasheet,“Inflavonoid Intensive Care™” Curcumin & Boswellia Complex, downloaded from internet on Mar. 28, 2002: http://www.doctorshealthsupply.com/metagenics/inflavonoid_intensive_care.htm, last edited Feb. 26, 2002 11:44 p.m., pp. 1-3.
Kiuchi, F., et al.; Inhibition ofProstaglandin and Leukotriene Biosynthesis by Gingerols and Diarylheptanoids; Chem Pharm Bull 1992; 40(2): 387-391.
Garrett, NE, et al.; Effect of capsaicin on substance P and nerve growth factor in adjuvant arthritic rats; Neuroscience Let 1997; 230(1):5-8.
Ammon, HP, et al.; Mechanism of antiinflammatory actions of curcumine and boswellic acids; J Ethnopharmacology 1993; 38(2-3): 113-119.
Safayhi H.; Boswellic Acids: Novel, Specific, Nonredox Inhibitors of 5-Lipoxygenase; J Pharmacol Exp Ther 1992; 261(3): 1143-1146.
Kulkami RR, et al.; Treatment of osteoarthritis with a herbomineral formulation: a double-blind, placebo-controlled, cross-over study; J. Ethnopharmacology 1991:33 (1-2): 91-95.
Srivastava KC, et al.; Ginger (Zingiber officinale) in Rheumatism and Musculosskeletal Disorders; Med Hypotheses 1992; 39(4): 342-348.
Guh JH, et al.; Antiplatelet Effect of Gingerol Isolated from Zingiber officinale; J Pharmacol 1995; 47(4):329-332.
Kaul TN, et al.; Antiviral Effects of Flavonoids on Human Viruses; J Med Virol 1985;15: 71-79.
Vrijsen R., et al.; Antiviral Activity of Flavones and Potentiation by Ascorbate; J Gen Virol 1988; 69:1749-51.
Lilling Herbert J.
McDermott Will & Emery LLP
Metagenics, Inc.
LandOfFree
Method for treatment of inflammation and pain in mammals does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method for treatment of inflammation and pain in mammals, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method for treatment of inflammation and pain in mammals will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3405665